Back to Treatments

Treatment

Ruxolitinib Cream (Opzelura)

1
Conditions
1
Trials
1,200
Participants
60%
Average Safety

Condition Evidence

Vitiligo

1 trials · 1,200 participants

75% effectiveness · 60% safety
Ruxolitinib Cream (Opzelura) | DFDA